Broad Institute

JUNE 24, 2025

Based on a technology developed by Broad Institute core member David Liu’s laboratory, the treatment is the first in a series of new medicines being tested to treat rare diseases by repairing patients’ particular genetic misspellings. Some of these treatments, like K.J.’s, The team that treated K.J. Today, K.J.

Treatment 133

Treatment Disease DNA Clinical Trials 133

The Pharma Data

NOVEMBER 2, 2020

billion cumulative treatments to more than 923 million people since 2000. The treatments target the parasites in the blood of infected people and prevent the risk of transmission in the community. Setting sights on 2030. Despite setbacks due to COVID-19, WHO will accelerate work to achieve this target by 2030.

Packaging 52

Packaging Disease Treatment Drugs 52

Agency IQ

MAY 10, 2024

In general, the law also pushes out a prohibition on almost all products with intentionally added PFAS from January 2030 to January 2032 , except for some cooling, heating, and refrigerant products which will be allowed until 2040.

Packaging 40

Packaging Regulations Production Compliance 40

Agency IQ

JUNE 28, 2024

In addition, the law prohibits the sale of carpets or fabric treatments containing PFAS as of January 1, 2023. In 2030, the law will ban the use of any product with intentionally added PFAS, unless the Maine legislature determines that the product currently serves an unavoidable use.

Production 40

Production Regulations Compliance Packaging 40

The Pharma Data

NOVEMBER 5, 2020

Lastly, we are proud that our novel antibody cocktail REGN-EB3 recently became the first FDA-approved treatment for Ebola, underscoring the potential of antibody therapies to address deadly infectious diseases.” ” “We continue to invest in our promising pipeline while delivering meaningful revenue and earnings growth.

Production 40

Production FDA Trials FDA Approval 40

The Pharma Data

JANUARY 9, 2021

CDMO Services assumes continued growth in Development Services (DVS), Drug Substance (DS) manufacturing, and Drug Product (DP) manufacturing and Packaging for both clinical- and commercial-stage projects on behalf of a growing list of pharmaceutical and biotechnology innovators and government/NGO customers. FOOTNOTES. (1)

Government 40

Government Vaccine Production Licensing 40

Agency IQ

DECEMBER 1, 2023

2040-AG17 Updates to the RCRA Hazardous Waste Permitting Regulations and Other Technical Corrections (Proposed Rule Stage) This action seeks to make regulatory amendments and various updates and clarifications to the Resource Conservation and Recovery Act subtitle C hazardous waste treatment, storage, and disposal and permitting standards.

Regulations 40

Regulations Production Science Compliance 40